USPTO Grants Reissuance Of Lovenox Patent
Three's the charm for French drug maker Sanofi-Aventis, whose bid for a reissuance of the U.S. patent for best-selling anti-blood clotting drug Lovenox finally has won approval from the U.S. Patent...To view the full article, register now.
Already a subscriber? Click here to view full article